| 1 | markers | 12,800 |
| 2 | suppressors | 109 |
| 3 | plasmacytosis | 4 |
| 4 | cross-recognition | 2 |
| 5 | haemopoiesis | 2 |
| 6 | markers/mediators | 2 |
| 7 | u14 | 2 |
| 8 | 9:224 | 1 |
| 9 | analysises | 1 |
| 10 | biter | 1 |
| 11 | changes.subjects | 1 |
| 12 | derived-cells | 1 |
| 13 | encephalitis/meningitis | 1 |
| 14 | hallmarkers | 1 |
| 15 | konservat-lagerstätte | 1 |
| 16 | level.we | 1 |
| 17 | levels-as | 1 |
| 18 | mini-arrays | 1 |
| 19 | modification-specifically | 1 |
| 20 | resposes | 1 |
| 21 | risk-enrolled | 1 |
| 22 | self-surfaces | 1 |
| 23 | values/moms | 1 |
| 24 | ≤200/µl | 1 |
| 1 | 9:224 | 1 |
| 2 | analysises | 1 |
| 3 | biter | 1 |
| 4 | changes.subjects | 1 |
| 5 | cross-recognition | 2 |
| 6 | derived-cells | 1 |
| 7 | encephalitis/meningitis | 1 |
| 8 | haemopoiesis | 2 |
| 9 | hallmarkers | 1 |
| 10 | konservat-lagerstätte | 1 |
| 11 | level.we | 1 |
| 12 | levels-as | 1 |
| 13 | markers | 12,800 |
| 14 | markers/mediators | 2 |
| 15 | mini-arrays | 1 |
| 16 | modification-specifically | 1 |
| 17 | plasmacytosis | 4 |
| 18 | resposes | 1 |
| 19 | risk-enrolled | 1 |
| 20 | self-surfaces | 1 |
| 21 | suppressors | 109 |
| 22 | u14 | 2 |
| 23 | values/moms | 1 |
| 24 | ≤200/µl | 1 |
| 1 | u14 | 2 |
| 2 | 9:224 | 1 |
| 3 | risk-enrolled | 1 |
| 4 | konservat-lagerstätte | 1 |
| 5 | level.we | 1 |
| 6 | ≤200/µl | 1 |
| 7 | cross-recognition | 2 |
| 8 | biter | 1 |
| 9 | levels-as | 1 |
| 10 | self-surfaces | 1 |
| 11 | analysises | 1 |
| 12 | resposes | 1 |
| 13 | haemopoiesis | 2 |
| 14 | plasmacytosis | 4 |
| 15 | encephalitis/meningitis | 1 |
| 16 | derived-cells | 1 |
| 17 | values/moms | 1 |
| 18 | markers | 12,800 |
| 19 | hallmarkers | 1 |
| 20 | suppressors | 109 |
| 21 | markers/mediators | 2 |
| 22 | changes.subjects | 1 |
| 23 | mini-arrays | 1 |
| 24 | modification-specifically | 1 |